Save time and get answers to complex questions with AI chat
Dabrafenib patent expiration date novartis gsk composition matter?Albendazole side effects in humans?Defense strategy against generic in niche market?Tenofovir generic patent?Are there income restrictions for lipitor's patient program?
See the DrugPatentWatch profile for maci
FDA Approval Date for Macitentan (“Maci”) The FDA granted approval for macitentan (brand‑name Macitentan) on September 9, 2011. It was approved as a once‑daily oral therapy for the treatment of pulmonary arterial hypertension (PAH). Source: FDA’s Drug Approval History and the “Macitentan” FDA approval page.
Other Questions About Maci :